Squarepoint Ops LLC

Position in ABSI — Absci Corp

CIK 1642575 NEW YORK, NY

Position in ABSI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,173,870

+$956,853 QoQ

Shares Held

391,290

+372.4% QoQ

Ownership

0.251%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,099,505,720 across 232 Biotechnology names. ABSI ranks #100 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,173,870	391,290	+372.4%	Shares	Defined	2026-05-15
2024-12-31	$217,017	82,831	-17.0%	Shares	Defined	2025-02-14
2024-09-30	$381,171	99,783	-73.0%	Shares	Defined	2024-11-14
2024-06-30	$1,137,095	369,187	+72.4%	Shares	Defined	2024-08-14
2024-03-31	$1,216,542	214,180	+100.8%	Shares	Defined	2024-05-15
2023-12-31	$448,093	106,689	-53.7%	Shares	Defined	2024-02-14
2023-09-30	$303,858	230,196	-23.7%	Shares	Defined	2023-11-14
2023-06-30	$458,676	301,761	+389.3%	Shares	Defined	2023-08-14
2023-03-31	$107,933	61,676	+86.8%	Shares	Defined	2023-05-15
2022-12-31	$69,335	33,017	+77.1%	Shares	Defined	2023-02-14
2022-06-30	$61,908	18,647	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.